Diana Mckenzie is Director of METLIFE INC. Currently has a direct ownership of 20,000 shares of MET, which is worth approximately $1.57 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 535 shares (Common Stock) at a price of $81.78 per share, resulting in proceeds of $43,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
3.5% 3M change
17.34% 12M change
Total Value Held $1.57 Million

DIANA MCKENZIE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
BUY
Grant, award, or other acquisition
$43,752 $81.78 p/Share
535 Added 2.61%
20,000 Common Stock
Sep 10 2024
BUY
Grant, award, or other acquisition
$10,522 $74.63 p/Share
141 Added 0.72%
19,465 Common Stock
Jun 18 2024
BUY
Grant, award, or other acquisition
$43,802 $69.86 p/Share
627 Added 3.14%
19,324 Common Stock
Jun 11 2024
BUY
Grant, award, or other acquisition
$10,082 $69.06 p/Share
146 Added 0.77%
18,697 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
$43,771 $73.69 p/Share
594 Added 3.1%
18,550 Common Stock
Mar 14 2024
BUY
Grant, award, or other acquisition
$9,275 $71.9 p/Share
129 Added 0.71%
17,956 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
$43,777 $67.35 p/Share
650 Added 3.52%
17,828 Common Stock
Dec 14 2023
BUY
Grant, award, or other acquisition
$8,830 $66.9 p/Share
132 Added 0.76%
17,178 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
$43,799 $61.69 p/Share
710 Added 4.0%
17,045 Common Stock
Sep 14 2023
BUY
Grant, award, or other acquisition
$8,439 $65.93 p/Share
128 Added 0.78%
16,335 Common Stock
Jun 20 2023
BUY
Grant, award, or other acquisition
$43,779 $54.52 p/Share
803 Added 4.72%
16,207 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
$7,929 $53.94 p/Share
147 Added 0.95%
15,404 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
$43,767 $57.97 p/Share
755 Added 4.72%
15,257 Common Stock
Mar 14 2023
BUY
Grant, award, or other acquisition
$7,147 $59.07 p/Share
121 Added 0.83%
14,502 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
$2,223 $71.73 p/Share
31 Added 0.22%
14,381 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
$37,518 $72.15 p/Share
520 Added 3.5%
14,350 Common Stock
Dec 14 2022
BUY
Grant, award, or other acquisition
$6,846 $72.84 p/Share
94 Added 0.68%
13,830 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
$37,509 $62.62 p/Share
599 Added 4.18%
13,735 Common Stock
Sep 14 2022
BUY
Grant, award, or other acquisition
$6,508 $66.41 p/Share
98 Added 0.74%
13,136 Common Stock
Jun 21 2022
BUY
Grant, award, or other acquisition
$37,518 $62.53 p/Share
600 Added 4.4%
13,038 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
$6,186 $61.86 p/Share
100 Added 0.8%
12,438 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
$37,506 $70.5 p/Share
532 Added 4.13%
12,338 Common Stock
Mar 14 2022
BUY
Grant, award, or other acquisition
$5,628 $64.69 p/Share
87 Added 0.73%
11,806 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
$37,559 $63.23 p/Share
594 Added 4.82%
11,720 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
$5,290 $60.8 p/Share
87 Added 0.78%
11,126 Common Stock

Also insider at

VRTX
VERTEX PHARMACEUTICALS INC Healthcare
CHNG
Change Healthcare Inc.
AGL
agilon health, inc. Healthcare
DM

Diana Mckenzie

Director
Boston, MA

Track Institutional and Insider Activities on MET

Follow METLIFE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MET shares.

Notify only if

Insider Trading

Get notified when an Metlife Inc insider buys or sells MET shares.

Notify only if

News

Receive news related to METLIFE INC

Track Activities on MET